Community Healthcare Trust announced a dividend cut during its Q2 earnings call, retaining an estimated $25 to $30 million in annual cash flow previously earmarked for shareholder distributions. Management stated the capital will strengthen the balance sheet and finance accretive acquisitions in outpatient healthcare properties, a fragmented asset class where CHCT has operated since its 2015 spin-off from Healthcare Realty Trust.
The move marks a tactical shift for a REIT with a market capitalization below $500 million. CHCT's portfolio consists of 192 properties across 34 states, leased primarily to physician groups, ambulatory surgery centers, and diagnostic clinics. The company's historical strategy has been steady dividend growth funded by incremental acquisitions in the $3 to $8 million per-property range. The cut trades that predictability for deployment flexibility at a moment when seller expectations in healthcare real estate have softened.
The retained capital addresses two pressure points. First, CHCT's leverage ratio sits near the high end of its stated comfort zone, limiting access to acquisition financing without equity dilution. Retaining $25 to $30 million annually provides a self-funding mechanism for six to ten acquisitions per year at typical deal sizes, without issuing shares below net asset value. Second, the healthcare property sector has seen cap rate expansion of 50 to 75 basis points since late 2022, creating a window for disciplined buyers. CHCT's portfolio weighted-average lease term of 8.1 years gives it tenant stability while it waits for motivated sellers.
The risk is execution. Small-cap REITs cutting dividends typically face sustained selling pressure from income-focused shareholders, which can depress the stock below intrinsic value for quarters. CHCT's shares yield approximately 7.2% post-cut, competitive with larger healthcare REITs but without the liquidity or analyst coverage. The company's acquisition pipeline must deliver returns above its cost of capital to justify the trade. Management has not disclosed specific targets, but the $25 to $30 million annual retention implies a deal cadence of roughly one acquisition every 45 to 60 days to deploy the capital efficiently.
Allocators should monitor CHCT's next two earnings calls for acquisition volume, cap rates on new deals, and any balance sheet deleveraging. The first $10 to $15 million deployment will signal whether management can source deals at spreads wide enough to compensate for the dividend cut. Healthcare property fundamentals remain intact—outpatient visit volume is 4% above 2019 levels—but the market will need proof that retained capital translates to NAV accretion.
The test is Q3 and Q4 2025. If CHCT closes four to six acquisitions at cap rates 100 basis points above its cost of capital, the cut becomes strategic repositioning. If deal flow stalls, it becomes a missed opportunity to return capital when growth was unavailable.